1620 Investment Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-6,422
Closed -$45K – 671
2025
Q4
$45K Sell
6,422
-299
-4% -$2.34K 0.03% 310
2025
Q3
$52K Sell
6,721
-15
-0.2% -$117 0.04% 287
2025
Q2
$58.7K Buy
+6,736
New +$48.8K 0.04% 290

Other funds holding TDOC

1620 Investment Advisors's TDOC Position: Q1 2026 in Review

1620 Investment Advisors sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 6,422 shares — an estimated $45K sold.

1620 Investment Advisors first reported a position in TDOC in Q2 2025 and held it in 3 quarters. The position peaked at $58.7K in Q2 2025. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • 1620 Investment Advisors reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • 1620 Investment Advisors sold 6,422 Teladoc Health shares in Q1 2026, an estimated $45K.
  • 1620 Investment Advisors first reported a position in Teladoc Health in Q2 2025 and held it in 3 quarters.
  • 1620 Investment Advisors's Teladoc Health position peaked at $58.7K in Q2 2025.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on 1620 Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.